Cardinal Health, Inc. (NYSE:CAH) Shares Bought by Mizuho Securities USA LLC

Mizuho Securities USA LLC grew its position in Cardinal Health, Inc. (NYSE:CAH) by 45.1% in the 4th quarter, Holdings Channel.com reports. The fund owned 22,937 shares of the company’s stock after acquiring an additional 7,125 shares during the quarter. Mizuho Securities USA LLC’s holdings in Cardinal Health were worth $2,713,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of CAH. Mirae Asset Global Investments Co. Ltd. grew its position in Cardinal Health by 35.2% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 32,520 shares of the company’s stock worth $3,871,000 after purchasing an additional 8,471 shares during the last quarter. CHURCHILL MANAGEMENT Corp increased its position in Cardinal Health by 1.5% in the 4th quarter. CHURCHILL MANAGEMENT Corp now owns 240,422 shares of the company’s stock valued at $28,435,000 after acquiring an additional 3,576 shares during the period. Geode Capital Management LLC raised its stake in Cardinal Health by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock valued at $633,298,000 after acquiring an additional 42,082 shares during the last quarter. Consolidated Planning Corp lifted its position in Cardinal Health by 40.0% during the 4th quarter. Consolidated Planning Corp now owns 8,926 shares of the company’s stock worth $1,056,000 after acquiring an additional 2,552 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Cardinal Health by 2.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company’s stock valued at $162,976,000 after purchasing an additional 33,388 shares during the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Stock Up 1.0 %

Shares of CAH stock opened at $133.25 on Tuesday. The stock has a market cap of $32.19 billion, a P/E ratio of 24.86, a P/E/G ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $133.67. The business has a fifty day simple moving average of $127.60 and a 200-day simple moving average of $120.24.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. On average, sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.52%. Cardinal Health’s dividend payout ratio is currently 37.69%.

Analyst Ratings Changes

CAH has been the subject of several analyst reports. Citigroup upped their price target on Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a research note on Friday, January 10th. JPMorgan Chase & Co. raised their target price on shares of Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Argus set a $148.00 price target on shares of Cardinal Health in a research note on Tuesday, February 4th. TD Cowen upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and raised their price objective for the company from $130.00 to $144.00 in a research report on Wednesday, January 8th. Finally, Wells Fargo & Company boosted their target price on Cardinal Health from $135.00 to $136.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 4th. Four research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus price target of $139.36.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.